Production (Stage)
CorMedix Inc.
CRMD
$12.36
$0.100.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.64M | 13.46M | -2.78M | -14.15M | -14.47M |
| Total Depreciation and Amortization | 161.90K | 133.70K | 77.40K | 76.90K | 21.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.55M | 1.37M | 1.26M | 1.30M | 2.48M |
| Change in Net Operating Assets | -4.62M | -20.58M | -12.22M | -1.27M | -5.35M |
| Cash from Operations | 19.74M | -5.61M | -13.65M | -14.04M | -17.31M |
| Capital Expenditure | -10.20K | -9.90K | -9.80K | -34.80K | -61.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -184.60K | -294.30K | 6.33M | 6.30M | 9.01M |
| Cash from Investing | -194.80K | -304.20K | 6.32M | 6.27M | 8.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.11M | 11.34M | 14.07M | 1.20M | -- |
| Repurchase of Common Stock | -1.02M | -53.00K | 0.00 | -139.50K | -97.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.09M | 11.28M | 14.07M | 1.06M | -97.10K |
| Foreign Exchange rate Adjustments | 200.00 | -1.20K | 400.00 | -100.00 | -800.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.63M | 5.36M | 6.75M | -6.71M | -8.46M |